← Leaderboards
Mark Jonathan Niedre
Northeastern University
$6,505,876
Attributed
$7,314,414
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $758.4K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,314,414 · 6
By mechanism
R01$6,506,539 · 4
R21$807,875 · 2
Top collaborators
- Heather A Clark5 shared
Most similar at Northeastern University
Same institution · by research overlap
- Kevin Joseph Cash$524,673
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignAnimalsTechnologyIn VivoLightTissuesFluorescenceOpticsDetectionFlow CytometryBlood VesselsInstrumentBlood VolumeBlood CirculationBlood SpecimenSamplingDiffusePeripheral BloodBloodAreaNeoplasm MetastasisResponseLasersAffect
Grant awards (21)
Continuous, Non-Invasive Optical Monitoring of Circulating Tumor Cell-Mediated Metastasis in Awake Mice$580,950
R01 · FY2025 · CA · contact PI
Continuous, Non-Invasive Optical Monitoring of Circulating Tumor Cell-Mediated Metastasis in Awake Mice$576,034
R01 · FY2024 · CA · contact PI
Continuous, Non-Invasive Optical Monitoring of Circulating Tumor Cell-Mediated Metastasis in Awake Mice$519,595
R01 · FY2023 · CA · contact PI
Continuous, Non-Invasive Optical Monitoring of Circulating Tumor Cell-Mediated Metastasis in Awake Mice$441,188
R01 · FY2022 · CA · contact PI
Fluorescence Molecular In Vivo Liquid Biopsy of Circulating Tumor Cells$179,825
R21 · FY2022 · CA · contact PI
Circulating Red Blood Cell Based Nanosensors for Continuous, Real-Time Drug Monitoring$346,241
R01 · FY2021 · EB
Fluorescence Molecular In Vivo Liquid Biopsy of Circulating Tumor Cells$209,534
R21 · FY2021 · CA · contact PI
Circulating Red Blood Cell Based Nanosensors for Continuous, Real-Time Drug Monitoring$353,250
R01 · FY2020 · EB
Circulating Red Blood Cell Based Nanosensors for Continuous, Real-Time Drug Monitoring$211,086
R01 · FY2020 · EB
Circulating Red Blood Cell Based Nanosensors for Continuous, Real-Time Drug Monitoring$353,250
R01 · FY2019 · EB
Ultra-Rare Cell In Vivo Flow Cytometry$405,166
R01 · FY2018 · HL · contact PI
Circulating Red Blood Cell Based Nanosensors for Continuous, Real-Time Drug Monitoring$353,250
R01 · FY2018 · EB
Ultra-Rare Cell In Vivo Flow Cytometry$406,018
R01 · FY2017 · HL · contact PI
Ultra-Rare Cell In Vivo Flow Cytometry$353,550
R01 · FY2016 · HL · contact PI
Ultra-Rare Cell In Vivo Flow Cytometry$348,100
R01 · FY2015 · HL · contact PI
High Resolution Multiplexed Fluorescence Tomography$320,638
R01 · FY2013 · EB · contact PI
High Resolution Multiplexed Fluorescence Tomography$330,417
R01 · FY2012 · EB · contact PI
High Resolution Multiplexed Fluorescence Tomography$297,891
R01 · FY2011 · EB · contact PI
Tomographic In Vivo Flow Cytometer for Counting Rare Circulating Cells$206,916
R21 · FY2011 · HL · contact PI
High Resolution Multiplexed Fluorescence Tomography$309,915
R01 · FY2010 · EB · contact PI
Tomographic In Vivo Flow Cytometer for Counting Rare Circulating Cells$211,600
R21 · FY2010 · HL · contact PI